Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Change in Receivables (2017 - 2025)

Catheter Precision (VTAK) has disclosed Change in Receivables for 9 consecutive years, with $32000.0 as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 186.49% to $32000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $85000.0 through Dec 2025, up 226.87% year-over-year, with the annual reading at $85000.0 for FY2025, 226.87% up from the prior year.
  • Change in Receivables for Q4 2025 was $32000.0 at Catheter Precision, up from $8000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $91000.0 in Q4 2023, with the low at -$83000.0 in Q3 2021.
  • Average Change in Receivables over 5 years is $2100.0, with a median of $9000.0 recorded in 2022.
  • The sharpest move saw Change in Receivables plummeted 8400.0% in 2021, then skyrocketed 533.33% in 2023.
  • Over 5 years, Change in Receivables stood at $51000.0 in 2021, then crashed by 141.18% to -$21000.0 in 2022, then surged by 533.33% to $91000.0 in 2023, then tumbled by 140.66% to -$37000.0 in 2024, then soared by 186.49% to $32000.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at $32000.0, $8000.0, and $29000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.